🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 15 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/06/2000 63,38 66,00 59,25 60,00 -6,98% 10,65% 23.483
21/06/2000 66,38 66,38 63,75 64,50 -2,27% 3,95% 6.900
20/06/2000 66,75 67,50 63,75 66,00 +1,15% 5,62% 12.733
19/06/2000 64,13 67,88 63,38 65,25 +0,00% 7,02% 18.217
16/06/2000 73,13 74,25 61,13 65,25 -10,77% 17,95% 15.117
15/06/2000 73,50 75,00 72,75 73,13 -0,51% 3,06% 2.550
14/06/2000 77,25 78,00 72,00 73,50 -3,92% 7,77% 10.917
13/06/2000 76,50 78,00 72,00 76,50 +0,99% 7,84% 12.683
12/06/2000 79,50 81,38 75,38 75,75 -3,81% 7,55% 11.317
09/06/2000 73,50 80,25 73,31 78,75 +8,81% 9,44% 26.050
08/06/2000 72,56 73,13 70,50 72,38 +0,52% 3,62% 12.833
07/06/2000 73,13 75,00 69,00 72,00 -2,04% 8,21% 18.333
06/06/2000 67,50 77,63 66,75 73,50 +11,36% 16,11% 49.500
05/06/2000 62,63 66,00 62,25 66,00 +4,76% 5,99% 20.000
02/06/2000 61,50 63,38 61,50 63,00 +1,20% 3,05% 17.533
01/06/2000 60,94 62,63 59,63 62,25 +4,40% 4,92% 11.717
31/05/2000 58,88 61,50 58,50 59,63 +1,92% 5,10% 11.400
30/05/2000 56,63 59,63 54,75 58,50 +5,41% 8,61% 19.900
26/05/2000 54,00 57,00 51,75 55,50 +2,78% 9,72% 22.117
25/05/2000 52,13 55,50 52,13 54,00 +3,60% 6,47% 13.733
24/05/2000 57,00 57,00 45,75 52,13 -6,08% 19,74% 27.383
23/05/2000 58,50 59,63 55,50 55,50 +0,00% 7,05% 9.417
22/05/2000 60,38 60,75 51,00 55,50 -7,50% 16,15% 13.917
19/05/2000 57,94 60,00 55,13 60,00 +5,26% 8,41% 19.633
18/05/2000 60,00 60,00 55,50 57,00 -3,80% 7,50% 10.100
17/05/2000 55,13 60,19 55,13 59,25 +1,28% 9,18% 12.167
16/05/2000 56,06 59,25 56,06 58,50 +4,70% 5,69% 10.283
15/05/2000 54,00 55,88 52,88 55,88 +0,68% 5,56% 11.283
12/05/2000 57,00 57,00 54,00 55,50 +1,37% 5,26% 10.283
11/05/2000 54,75 56,25 54,00 54,75 +1,39% 4,11% 9.183